These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
685 related articles for article (PubMed ID: 26472030)
61. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc. Daniel M; Tollefsbol TO J Cell Biochem; 2018 Apr; 119(4):3326-3337. PubMed ID: 29125889 [TBL] [Abstract][Full Text] [Related]
62. Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells. Ke S; Zhou F; Yang H; Wei Y; Gong J; Mei Z; Wu L; Yu H; Zhou Y Int J Oncol; 2015 Mar; 46(3):1051-8. PubMed ID: 25501936 [TBL] [Abstract][Full Text] [Related]
63. Distinct modulation of telomere length in two T-lymphoblastic leukemia cell lines by cytotoxic nucleoside phosphonates PMEG and PMEDAP. Hájek M; Cvilink V; Votruba I; Holý A; Mertlíková-Kaiserová H Eur J Pharmacol; 2010 Sep; 643(1):6-12. PubMed ID: 20599933 [TBL] [Abstract][Full Text] [Related]
64. Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells. Iskandarani A; Bhat AA; Siveen KS; Prabhu KS; Kuttikrishnan S; Khan MA; Krishnankutty R; Kulinski M; Nasr RR; Mohammad RM; Uddin S J Transl Med; 2016 Mar; 14():69. PubMed ID: 26956626 [TBL] [Abstract][Full Text] [Related]
65. Human telomerase reverse transcriptase (hTERT): a target molecule for the treatment of cisplatin-resistant tumors. Park YP; Kim KD; Kang SH; Yoon DY; Park JW; Kim JW; Lee HG Korean J Lab Med; 2008 Dec; 28(6):430-7. PubMed ID: 19127107 [TBL] [Abstract][Full Text] [Related]
66. Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells. Biroccio A; Gabellini C; Amodei S; Benassi B; Del Bufalo D; Elli R; Antonelli A; D'Incalci M; Zupi G Mol Pharmacol; 2003 Mar; 63(3):632-8. PubMed ID: 12606771 [TBL] [Abstract][Full Text] [Related]
67. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Misawa M; Tauchi T; Sashida G; Nakajima A; Abe K; Ohyashiki JH; Ohyashiki K Int J Oncol; 2002 Nov; 21(5):1087-92. PubMed ID: 12370759 [TBL] [Abstract][Full Text] [Related]
68. Downregulation of hTERT: an important As2O3 induced mechanism of apoptosis in myelodysplastic syndrome. Xu W; Wang Y; Tong H; Qian W; Jin J PLoS One; 2014; 9(11):e113199. PubMed ID: 25415199 [TBL] [Abstract][Full Text] [Related]
69. Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors. Franke NE; Kaspers GL; Assaraf YG; van Meerloo J; Niewerth D; Kessler FL; Poddighe PJ; Kole J; Smeets SJ; Ylstra B; Bi C; Chng WJ; Horton TM; Menezes RX; Musters RJ; Zweegman S; Jansen G; Cloos J Oncotarget; 2016 Nov; 7(46):74779-74796. PubMed ID: 27542283 [TBL] [Abstract][Full Text] [Related]
70. [New insight into the mechanism of p53 inducing leukemia cell apoptosis]. Chen YZ; Wu Y; Liang M; Li NN; Zhang ZX; Lu LH Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612 [TBL] [Abstract][Full Text] [Related]
71. CTC1-STN1 terminates telomerase while STN1-TEN1 enables C-strand synthesis during telomere replication in colon cancer cells. Feng X; Hsu SJ; Bhattacharjee A; Wang Y; Diao J; Price CM Nat Commun; 2018 Jul; 9(1):2827. PubMed ID: 30026550 [TBL] [Abstract][Full Text] [Related]
72. [Study on the mechanisms of telomerase regulations during apoptosis of the human MDS-RAEB cell line MUTZ-1 cells induced by arsenic trioxide]. Tong HY; Jin J; Xu WL; Qian WB; Lin MF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):615-9. PubMed ID: 16129045 [TBL] [Abstract][Full Text] [Related]
73. Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors. Zhang H; Yang MH; Zhao JJ; Chen L; Yu ST; Tang XD; Fang DC; Yang SM Oncol Rep; 2010 Oct; 24(4):1059-65. PubMed ID: 20811689 [TBL] [Abstract][Full Text] [Related]
74. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression. Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819 [TBL] [Abstract][Full Text] [Related]
75. hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation. Hu C; Ni Z; Li BS; Yong X; Yang X; Zhang JW; Zhang D; Qin Y; Jie MM; Dong H; Li S; He F; Yang SM Gut; 2017 Jan; 66(1):31-42. PubMed ID: 26370108 [TBL] [Abstract][Full Text] [Related]
76. Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration. Gomez D; Aouali N; Londoño-Vallejo A; Lacroix L; Mégnin-Chanet F; Lemarteleur T; Douarre C; Shin-ya K; Mailliet P; Trentesaux C; Morjani H; Mergny JL; Riou JF J Biol Chem; 2003 Dec; 278(50):50554-62. PubMed ID: 14525974 [TBL] [Abstract][Full Text] [Related]
77. [Effects of vinorelbine on apoptosis and expression of telomerase activity in human lung adenocarcinoma cells in vitro]. Liu JJ; Chen GY; Wang M; Yang ZY; Hong X Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):743-7. PubMed ID: 21163063 [TBL] [Abstract][Full Text] [Related]
78. Visualizing the down-regulation of hTERT mRNA expression using gold-nanoflare probes and verifying the correlation with cancer cell apoptosis. Sun H; Hong M; Yang Q; Li C; Zhang G; Yue Q; Ma Y; Li X; Li CZ Analyst; 2019 May; 144(9):2994-3004. PubMed ID: 30892312 [TBL] [Abstract][Full Text] [Related]
79. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461. Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594 [TBL] [Abstract][Full Text] [Related]
80. Ablation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism. La SH; Kim SJ; Kang HG; Lee HW; Chun KH Oncotarget; 2016 Aug; 7(35):57117-57130. PubMed ID: 27494887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]